SYROS PHARMACEUTICALS, INC. Long-Term Debt, Maturity, Year Two
SYROS PHARMACEUTICALS, INC. had Long-Term Debt, Maturity, Year Two of $17.14 million as of 2024-09-30, per its 10-Q filed 2024-10-31.
Financial Statements › Notes › Commitment and Contingencies › Long-Term Debt, Fiscal Year Maturity › Long-Term Debt, Maturity, Year Two and Three
us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo · last filed 2024-10-31
- 2024-09-30: Long-Term Debt, Maturity, Year Two $17.14M.
- 2024-06-30: Long-Term Debt, Maturity, Year Two $17.14M.
- 2024-03-31: Long-Term Debt, Maturity, Year Two $13.33M.
- 2023-12-31: Long-Term Debt, Maturity, Year Two $20.00M.
| Period end | Long-Term Debt, Maturity, Year Two |
|---|---|
| 2024-09-30 | $17.14M 10-Q · filed 2024-10-31 |
| 2024-06-30 | $17.14M 10-Q · filed 2024-07-31 |
| 2024-03-31 | $13.33M 10-Q · filed 2024-05-14 |
| 2023-12-31 | $20.00M 10-K · filed 2024-03-27 |
| 2023-09-30 | $20.00M 10-Q · filed 2023-11-14 |
| 2023-06-30 | $20.00M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $20.00M 10-Q · filed 2023-05-10 |
| 2022-12-31 | $16.67M 10-K · filed 2023-03-02 |
| 2022-09-30 | $15.00M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $20.00M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $20.00M 10-Q · filed 2022-05-16 |
| 2021-12-31 | $16.67M 10-K · filed 2022-03-15 |
| 2021-09-30 | $16.67M 10-Q · filed 2021-11-05 |
| 2021-06-30 | $16.67M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $16.67M 10-Q · filed 2021-05-06 |